Meihua International Medical Technologies Co Ltd Quick Ratio (MHUA) starting from the fourth quarter 2025 to fourth quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Meihua International Medical Technologies Co Ltd  (NASDAQ: MHUA)

Meihua International Medical Technologies Co Ltd's Quick Ratio

MHUA's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Current Liabilities decreased faster than Meihua International Medical Technologies Co Ltd's Cash & cash equivalent, this led to improvement in Meihua International Medical Technologies Co Ltd's Quick Ratio to 0.84, Quick Ratio remained below Meihua International Medical Technologies Co Ltd average.

Within Medical Equipment & Supplies industry 118 other companies have achieved higher Quick Ratio than Meihua International Medical Technologies Co Ltd in fourth quarter 2025. While Quick Ratio total ranking in the fourth quarter 2025 has deteriorated compared to the prior quarter from to 2036.

Explain Quick Ratio?
How much Cash & cash equivalents MHUA´s has?
What are MHUA´s Current Liabilities?




MHUA Quick Ratio (Dec 31 2025)
Q4
0
Q3
0
Q2
0
Q1
(Dec 31 2024)
Q4
Y / Y Current Liabilities Change -26.87 % 266.74 % 160.84 % -27.21 % 170.29 %
Y / Y Cash & cash equivalent Change -54.42 % 19.74 % -52.14 % 152.57 % 86.15 %
Quick Ratio MRQ 0.84 0.83 0.66 0.83 1.34
MHUA's Total Ranking # 2036 # # # #
Seq. Current Liabilities Change -0.76 % -22.83 % 29.58 % -26.3 % 397.63 %
Seq. Cash & cash equivalent Change 0 % -2.54 % 2.6 % -54.42 % 162.72 %



Quick Ratio fourth quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 119
Healthcare Sector # 654
Overall Market # 2036


Quick Ratio Statistics
High Average Low
1.11 0.87 0.68
(Dec 31 2022)   (Dec 31 2023)




Financial Statements
Meihua International Medical Technologies Co Ltd's Current Liabilities $ 18 Millions Visit MHUA's Balance sheet
Meihua International Medical Technologies Co Ltd's Cash & cash equivalent $ 15 Millions Visit MHUA's Balance sheet
Source of MHUA's Sales Visit MHUA's Sales by Geography


Cumulative Meihua International Medical Technologies Co Ltd's Quick Ratio

MHUA's Quick Ratio for the trailling 12 Months

MHUA Quick Ratio

(Dec 31 2025)
12 Months
0
12 Months
0
12 Months
0
12 Months
(Dec 31 2024)
12 Months
Y / Y Current Liabilities TTM Growth 22.51 % 75.89 % 4.78 % -15.05 % -3.61 %
Y / Y Cash & cash equivalent TTM Growth -27.71 % 14.64 % 16.16 % 7.61 % -21.62 %
Quick Ratio TTM 0.78 0.93 1.07 1.64 1.32
Total Ranking TTM # 3115 # # # #
Seq. Current Liabilities TTM Growth -7.84 % 18.53 % 25.56 % -10.68 % 32.32 %
Seq. Cash & cash equivalent TTM Growth -22.87 % 3.26 % -18.11 % 10.85 % 22.3 %


On the trailing twelve months basis In spite of the year on year decrease in MHUA's Current Liabilities to $18.11 millions, cumulative Quick Ratio to 0.78 below the MHUA average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 173 other companies have achieved higher Quick Ratio than Meihua International Medical Technologies Co Ltd. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2025 from to 3115.

Explain Quick Ratio?
How much Cash & cash equivalents MHUA´s has?
What are MHUA´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 174
Healthcare Sector # 805
Within the Market # 3115


trailing twelve months Quick Ratio Statistics
High Average Low
1.11 0.93 0.68
(Dec 31 2022)   (Dec 31 2023)




Companies with similar Quick Ratio in the quarter ending Dec 31 2025, within Medical Equipment & Supplies Industry Quick RatioDec 31 2025 MRQ Cash & cash equivalentDec 31 2025 MRQ Current Liabilities
Capsovision Inc   2.28 $ 10.112  Millions$ 4.427  Millions
Sharps Technology Inc   2.21 $ 10.383  Millions$ 4.695  Millions
Tactile Systems Technology Inc   2.21 $ 83.446  Millions$ 37.762  Millions
Myomo Inc   2.20 $ 18.394  Millions$ 8.345  Millions
Inogen Inc   2.18 $ 119.577  Millions$ 54.869  Millions
Atricure Inc   2.05 $ 167.428  Millions$ 81.520  Millions
Edwards Lifesciences Corporation  1.99 $ 5,526.800  Millions$ 2,773.600  Millions
Axogen inc   1.96 $ 41.528  Millions$ 21.184  Millions
Nephros Inc   1.95 $ 5.400  Millions$ 2.767  Millions
Merit Medical Systems Inc  1.95 $ 446.404  Millions$ 228.888  Millions
Polypid Ltd  1.93 $ 13.126  Millions$ 6.786  Millions
Warby Parker Inc   1.91 $ 286.358  Millions$ 150.130  Millions
Medinotec Inc   1.88 $ 2.770  Millions$ 1.477  Millions
Vaso Corporation  1.84 $ 34.081  Millions$ 18.497  Millions
Neuraxis Inc   1.83 $ 4.965  Millions$ 2.710  Millions
Trisalus Life Sciences Inc   1.78 $ 20.439  Millions$ 11.499  Millions
Pulsenmore Ltd   1.75 $ 6.773  Millions$ 3.860  Millions
Si bone inc   1.74 $ 42.240  Millions$ 24.335  Millions
Genedx Holdings Corp   1.64 $ 171.282  Millions$ 104.504  Millions
Treace Medical Concepts Inc   1.58 $ 48.367  Millions$ 30.635  Millions
Glucotrack Inc   1.55 $ 7.383  Millions$ 4.773  Millions
Global Innovative Platforms Inc.  1.53 $ 0.018  Millions$ 0.012  Millions
Alphatec Holdings Inc   1.53 $ 160.806  Millions$ 105.419  Millions
Electromed Inc   1.46 $ 15.287  Millions$ 10.468  Millions
Qhslab Inc   1.41 $ 0.636  Millions$ 0.450  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  1.41 $ 10.412  Millions$ 7.405  Millions
Beyond Air Inc   1.38 $ 6.917  Millions$ 5.000  Millions
Tandem Diabetes Care Inc   1.37 $ 292.666  Millions$ 213.725  Millions
Neuronetics Inc   1.37 $ 34.134  Millions$ 24.960  Millions
Heartbeam Inc   1.35 $ 4.380  Millions$ 3.240  Millions

Date modified: 2026-07-07T11:58:39+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.